To take your ideas to Policymakers, Join the Campaign of #PolicyPulse Write to feedback@policypulse.com

India’s pharma industry may grow to $55 billion

Sector has a competitive edge over others since its productions costs are lower than many countries

Policy Pulse
Publish Date: Jul 4 2016 10:23AM | Updated Date: Jul 4 2016 10:23AM

India’s pharma industry may grow to $55 billion

Demo photo

 

Country’s growing pharmaceutical market may grow to $55 billion by 2020 and become  sixth largest globally by size, Indian ambassador to the US Arun Singh has said in New York.

 
While inaugurating the 34th annual convention of the American Association of Physicians of Indian Origin (AAPI) in the US city, he spoke on the rapid growth of the health sector in India, especially in pharmaceuticals.
 
Sector had a competitive edge over others since its productions costs were considerably lower than that of the US and several parts of Europe, he said.
 
The ambassador added that branded generics control the pharmaceuticals market, constituting almost 70 to 80 per cent of the market
 
India is the largest provider of generic drugs worldwide with Indian generics accounting for 20 per ent of global exports in terms of volume, Singh said further.